Second line of treatment for HER2-positive gastric cancer: an evolving issue

por Roviello, Giandomenico, Catalano, Martina, D’Angelo, Alberto, Palmieri, Valeria Emma
Publicado en Rep Pract Oncol Radiother (2021)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

por Roviello, Giandomenico, D'Angelo, Alberto, Roudi, Raheleh, Petrioli, Roberto, Mini, Enrico
Publicado en J Oncol (2019)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

por Roviello, Giandomenico, Corona, Silvia Paola, D’Angelo, Alberto, Rosellini, Pietro, Nobili, Stefania, Mini, Enrico
Publicado en Int J Mol Sci (2020)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy

por Rodriquenz, Maria Grazia, Roviello, Giandomenico, D’Angelo, Alberto, Lavacchi, Daniele, Roviello, Franco, Polom, Karol
Publicado en J Clin Med (2020)

Mutant p53 as an Antigen in Cancer Immunotherapy

por Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Publicado en Int J Mol Sci (2020)

Advances in anti-BRAF therapies for lung cancer

por Roviello, Giandomenico, D’Angelo, Alberto, Sirico, Marianna, Pittacolo, Matteo, Conter, Felipe Umpierre, Sobhani, Navid
Publicado en Invest New Drugs (2021)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

por Roviello, Giandomenico, D'Angelo, Alberto, Petrioli, Roberto, Roviello, Franco, Cianchi, Fabio, Nobili, Stefania, Mini, Enrico, Lavacchi, Daniele
Publicado en Transl Oncol (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

por Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Publicado en Cells (2018)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

por Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Publicado en Int J Mol Sci (2021)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

por Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
Publicado en Cells (2019)

Methylene Blue—Current Knowledge, Fluorescent Properties, and Its Future Use

por Cwalinski, Tomasz, Polom, Wojciech, Marano, Luigi, Roviello, Giandomenico, D’Angelo, Alberto, Cwalina, Natalia, Matuszewski, Marcin, Roviello, Franco, Jaskiewicz, Janusz, Polom, Karol
Publicado en J Clin Med (2020)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

por D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Publicado en Cancers (Basel) (2020)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

por D’Angelo, Alberto, Sobhani, Navid, Roviello, Giandomenico, Bagby, Stefan, Bonazza, Deborah, Bottin, Cristina, Giudici, Fabiola, Zanconati, Fabrizio, De Manzini, Nicolo, Guglielmi, Alessandra, Generali, Daniele
Publicado en PLoS One (2019)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

por Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
Publicado en Sci Rep (2020)